SUMIT MAHAJAN: Open Payments
NPI 1659350916 · YUCCA VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 8 payments from 6 companies in 2025. Trend: 2023 $775 · 2024 $797 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| ABBVIE INC. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: TRELEGY ELLIPTA, XIFAXAN, QULIPTA, Dexcom G6 Transmitter, YUPELRI, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
